SFX by Ex Libris Inc.

Title:	Modeling Chemical Interaction Profiles: II. Molecular Docking, Spectral Data-Activity Relationship, and Structure-Activity Relationship Models for Potent and Weak Inhibitors of Cytochrome P450 CYP3A4 Isozyme
Source:	Molecules [1420-3049] Tie, Yunfeng yr:2012

Basic

Full text

Full text available via PubMed Central

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Tyler, Crystal P. "Health care provider attitudes and practices related to intrauterine devices for nulliparous women." Obstetrics and gynecology 119.4 (2012): 762-771.
description	2.	Hu, L. "Predicting biological functions of compounds based on chemical-chemical interactions." PLoS ONE 6.12 (2011).
description	3.	Yu, Yanke K. "Examination of the Pharmacokinetics of Active Ingredients of Ginger in Humans." The AAPS journal 13.3 (2011): 417-426.
description	4.	Clay, M. "Stereoselective metabolism of tazofelone, an anti-inflammatory bowel disease agent, in rats and dogs and in human liver microsomes." Chirality 11.3 (1999): 233-240.
description	5.	Yang, L. "Effects of flavonoids on cytochrome P450-dependent acetaminophen metabolism in rats and human liver microsomes." Drug metabolism and disposition 22.4 (1994): 566-71.
description	6.	Hooton, Thomas M. "Clinical practice. Uncomplicated urinary tract infection." The New England journal of medicine 366.11 (2012): 1028-1037.
description	7.	Townsend, Mary K. "Caffeine Intake and Risk of Urinary Incontinence Progression Among Women." Obstetrics and gynecology 119.5 (2012): 950-958.
description	8.	GUPTA, RAJINDER K. "Synthesis of some recently isolated chalcones, their analogues and corresponding flavanones." Agricultural and Biological Chemistry 43.12 (1979): 2603-2605.
description	9.	Zick, Suzanna M. "Pharmacokinetics of 6-Gingerol, 8-Gingerol, 10-Gingerol, and 6-Shogaol and Conjugate Metabolites in Healthy Human Subjects." Cancer epidemiology biomarkers & prevention 17.8 (2008): 1930-1936.
description	10.	Lyus, R. "Use of the Mirena LNG-IUS and Paragard CuT380A intrauterine devices in nulliparous women." Contraception 81.5 (2010): 367-371.
description	11.	Ali, Badreldin H H. "Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): A review of recent research." Food and Chemical Toxicology 46.2 (2008): 409-20.
description	12.	Dugasani, S. "Comparative antioxidant and anti-inflammatory effects of [6]-gingerol, [8]-gingerol, [10]-gingerol and [6]-shogaol." Journal of ethnopharmacology 127.2 (2009): 515-520.
description	13.	Badea, S. "Advances in enantioselective analysis of chiral brominated flame retardants. Current status, limitations and future perspectives." Science of the total environment 566 (2016): 1120-1130.
description	14.	Wang, Z. "Characterizing the effect of cytochrome P450 (CYP) 2C8, CYP2C9, and CYP2D6 genetic polymorphisms on stereoselective N-demethylation of fluoxetine." Chirality 26.3 (2014): 166-73.
description	15.	Zetterstrm, R. "The discovery of misfolded prions as an infectious agent." Acta pædiatrica 99.12 (2010): 1910-1913.
description	16.	Bourrié, M.. "Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes." The Journal of pharmacology and experimental therapeutics 277.1 (1996): 321-332.
description	17.	Harper CC, Cynthia C C. "Challenges in translating evidence to practice: the provision of intrauterine contraception." Obstetrics and gynecology 111.6 (2008): 1359-1369.
description	18.	Aggarwal, Bharat B. "Potential of spice-derived phytochemicals for cancer prevention." Planta medica 74.13 (2008): 1560-1569.
description	19.	Bachmann, A S S. "Syringolin A, a new plant elicitor from the phytopathogenic bacterium Pseudomonas syringae pv. syringae, inhibits the proliferation of neuroblastoma and ovarian cancer cells and induces apoptosis." Cell proliferation 39.6 (2007): 599-609.
description	20.	Legardy, K. "Progestogen-only contraceptive use among women with sickle cell anemia: a systematic review." Contraception 73.2 (2006): 195-87.